CLINICAL & COST- EFFECTIVENESS OF NEURAMINIDASE INHIBITORS FOR THE TREATMENT & PREVENTION OF INFLUENZA Nicola Cooper, PhD & Alex Sutton, PhD Centre for.
School-based diabetes awareness and prevention education in India
mDiabetes: Leveraging Mobile Technology for Diabetes Prevention in India
Does Pharmacist Led Medication Review Improve Health Outcomes
Pneumococcal Vaccination in Adults
Rome, Italy - March 18-19, 2005 masque.... Humoral immune status: Comparison of various serological assays Catherine Sadzot-Delvaux Laboratory of Fundamental.
CHANGING THE COURSE OF CHRONIC DISEASE… One Community at a Time
Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM Report October 6, 2004
American Cancer Society Workplace Solutions
Treatment of Diabetes Mellitus Dr. Vereshchahina Natalija.
IOM Report on Financing Vaccines in the 21 st Century: National Vaccine Advisory Committee Follow-up Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM.
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
